Federal contract award
75F40122C00154
DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS CLAIMS THAT IS ALIGNED WITH REGULATORY REQUIREMENTS/DEMONSTRATE AND EMPIRICALLY TEST THE PROCESS WITH HISTORICAL AND ONGOING RCTS FOR SUPPLEMENTAL INDICATIONS/
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.7M |
| Current contract value | $2.7M |
| Potential contract value / ceiling | $2.7M |
| Start date | Sep 27, 2022 |
| Current end date | Jun 27, 2027 |
| Potential end date | Jun 27, 2027 |
| Latest award activity | Sep 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 1, 2026 | P00006 | $0 | EO 14398 - THE PURPOSE OF THE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE BY NINE MONTHS (FROM 09/28/2022 - 09/27/2026 TO 09/28/2022 - 06/27/2027) |
| May 19, 2026 | P00005 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 27, 2026.-COR CHANGE |
| Sep 11, 2025 | P00004 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 27, 2026. |
| Jun 11, 2025 | P00003 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ADD THE REMAINING CONTRACT AMOUNT OF $676,075.00 TO THE CONTRACT. |
| Aug 30, 2023 | P00002 | $676.1K | THE PURPOSE OF THIS MODIFICATION IS TO ADD THE REMAINING CONTRACT AMOUNT OF $676,075.00 TO THE CONTRACT. |
| Nov 22, 2022 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO REPLACE A KEY PERSONNEL WITH THE CONTRACTOR'S PROPOSED PERSONNEL. |
| Sep 27, 2022 | 0 | $2.0M | DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS CLAIMS THAT IS ALIGNED WITH REGULATORY REQUIREMENTS/DEMONSTRATE AND EMPIRICALLY TEST THE PROCESS WITH HISTORICAL AND ONGOING RCTS FOR SUPPLEMENTAL INDICATIONS/ |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2027-06-27 (245 days from calculation)
- +35 points
- 46 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-09-01
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.